共 49 条
Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold
被引:72
|作者:
Devine, Shane M.
[1
]
Mulcair, Mark D.
[1
]
Debono, Cael O.
[1
]
Leung, Eleanor W. W.
[1
]
Nissink, J. Willem M.
[2
]
Lim, San Sui
[1
]
Chandrashekaran, Indu R.
[1
]
Vazirani, Mansha
[1
]
Mohanty, Biswaranjan
[1
]
Simpson, Jamie S.
[1
]
Baell, Jonathan B.
[1
]
Scammells, Peter J.
[1
]
Norton, Raymond S.
[1
]
Scanlon, Martin J.
[1
]
机构:
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[2] AstraZeneca, Oncol iMed, Cambridge CB4 0WG, England
基金:
澳大利亚国家健康与医学研究理事会;
英国医学研究理事会;
关键词:
VIRTUAL EXPLORATION;
CHEMICAL UNIVERSE;
DRUG;
DISCOVERY;
DESIGN;
NMR;
STRATEGIES;
INHIBITORS;
MOLECULES;
LIBRARIES;
D O I:
10.1021/jm501402x
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
We have identified a class of molecules, known as 2-aminothiazoles (2-ATs), as frequent-hitting fragments in biophysical binding assays. This was exemplified by 4-phenylthiazol-2-amine being identified as a hit in 14/14 screens against a diverse range of protein targets, suggesting that this scaffold is a poor starting point for fragment-based drug discovery. This prompted us to analyze this scaffold in the context of an academic fragment library used for fragment-based drug discovery (FBDD) and two larger compound libraries used for high-throughput screening (HTS). This analysis revealed that such "promiscuous 2-aminothiazoles" (PrATs) behaved as frequent hitters under both FBDD and HTS settings, although the problem was more pronounced in the fragment-based studies. As 2-ATs are present in known drugs, they cannot necessarily be deemed undesirable, but the combination of their promiscuity and difficulties associated with optimizing them into a lead compound makes them, in our opinion, poor scaffolds for fragment libraries.
引用
收藏
页码:1205 / 1214
页数:10
相关论文